X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11474) 11474
Publication (662) 662
Book Review (151) 151
Book Chapter (73) 73
Newsletter (56) 56
Magazine Article (34) 34
Conference Proceeding (7) 7
Dissertation (7) 7
Book / eBook (6) 6
Reference (4) 4
Trade Publication Article (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7826) 7826
male (6387) 6387
female (4386) 4386
angiotensin-converting enzyme inhibitors - therapeutic use (4199) 4199
animals (3692) 3692
angiotensin-converting enzyme inhibitors - administration & dosage (3669) 3669
middle aged (3293) 3293
index medicus (2834) 2834
aged (2726) 2726
angiotensin-converting enzyme inhibitors - pharmacology (2688) 2688
hypertension - drug therapy (2671) 2671
blood pressure - drug effects (2474) 2474
rats (2342) 2342
adult (2221) 2221
hypertension (2180) 2180
pharmacology & pharmacy (1885) 1885
drug therapy, combination (1611) 1611
cardiac & cardiovascular systems (1596) 1596
treatment outcome (1390) 1390
angiotensin-converting enzyme inhibitors (1382) 1382
angiotensin-converting enzyme inhibitors - adverse effects (1344) 1344
peripheral vascular disease (1314) 1314
angiotensin (1287) 1287
angiotensin-converting enzyme (1249) 1249
heart failure - drug therapy (1238) 1238
captopril (1235) 1235
antihypertensive agents - therapeutic use (1197) 1197
antihypertensive agents - administration & dosage (1140) 1140
hypertension - physiopathology (1109) 1109
dose-response relationship, drug (1107) 1107
ace inhibitors (1084) 1084
time factors (1059) 1059
blood-pressure (1009) 1009
renin-angiotensin system - drug effects (1004) 1004
risk factors (987) 987
blood pressure (981) 981
enalapril (959) 959
mortality (927) 927
double-blind method (892) 892
heart failure (873) 873
captopril - pharmacology (802) 802
medicine, general & internal (802) 802
drug therapy (779) 779
enzymes (752) 752
renin-angiotensin system (751) 751
research (721) 721
adrenergic beta-antagonists - therapeutic use (709) 709
urology & nephrology (683) 683
aged, 80 and over (668) 668
angiotensin converting enzyme (656) 656
administration, oral (647) 647
antihypertensive agents - pharmacology (605) 605
enalapril - administration & dosage (598) 598
hemodynamics - drug effects (586) 586
angiotensin receptor antagonists (583) 583
dosage and administration (583) 583
care and treatment (578) 578
renin - blood (559) 559
follow-up studies (558) 558
rats, sprague-dawley (558) 558
rats, wistar (547) 547
heart rate - drug effects (543) 543
physiology (542) 542
hypertension - complications (540) 540
captopril - administration & dosage (538) 538
rats, inbred shr (528) 528
enalapril - therapeutic use (526) 526
calcium channel blockers - therapeutic use (518) 518
health aspects (518) 518
enalapril - pharmacology (504) 504
prospective studies (498) 498
angiotensin ii (497) 497
captopril - therapeutic use (495) 495
peptidyl-dipeptidase a - metabolism (495) 495
kidney - drug effects (493) 493
drug administration schedule (485) 485
heart-failure (483) 483
therapy (483) 483
retrospective studies (477) 477
randomized controlled trials as topic (473) 473
heart failure - physiopathology (472) 472
diuretics - therapeutic use (470) 470
adrenergic beta-antagonists - administration & dosage (467) 467
angiotensin ii type 1 receptor blockers - therapeutic use (465) 465
angiotensin-converting enzyme inhibitor (463) 463
myocardial-infarction (459) 459
disease (458) 458
mice (451) 451
physiological aspects (439) 439
adolescent (437) 437
myocardial infarction - drug therapy (437) 437
angiotensin-converting enzyme inhibitors - pharmacokinetics (436) 436
bradykinin (427) 427
calcium channel blockers - administration & dosage (424) 424
diabetes (420) 420
disease models, animal (419) 419
renin-angiotensin system - physiology (419) 419
prevention (415) 415
clinical trials as topic (413) 413
system (413) 413
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10497) 10497
German (260) 260
Russian (214) 214
Japanese (161) 161
French (138) 138
Spanish (66) 66
Italian (55) 55
Polish (41) 41
Danish (28) 28
Hungarian (25) 25
Chinese (24) 24
Swedish (23) 23
Norwegian (21) 21
Czech (19) 19
Portuguese (10) 10
Ukrainian (9) 9
Dutch (7) 7
Finnish (6) 6
Lithuanian (6) 6
Turkish (6) 6
Hebrew (5) 5
Korean (5) 5
Romanian (5) 5
Croatian (4) 4
Serbian (3) 3
Bosnian (2) 2
Slovak (2) 2
Bulgarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Medicine, The, ISSN 0002-9343, 2012, Volume 125, Issue 9, pp. 882 - 887.e1
Abstract Objective Combination therapy, specifically with aspirin, cholesterol and blood pressure-lowering drugs, substantially reduces the risk of coronary... 
Internal Medicine | Adherence | Prevention | Cardiovascular disease | PERSISTENCE | ACUTE CORONARY SYNDROMES | CONVERTING ENZYME-INHIBITORS | SECONDARY PREVENTION | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | STATIN THERAPY | ACUTE MYOCARDIAL-INFARCTION | BETA-BLOCKERS | MEDICATION ADHERENCE | ARTERY-DISEASE | Drug Costs | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Medication Adherence - statistics & numerical data | Cardiovascular Agents - administration & dosage | Age Factors | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Antihypertensive Agents - administration & dosage | Secondary Prevention - methods | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Aspirin - administration & dosage | Drug Prescriptions - statistics & numerical data | Self Administration | Time Factors | Anticholesteremic Agents - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Calcium Channel Blockers - administration & dosage | Primary Prevention - methods | Sodium Chloride Symporter Inhibitors - administration & dosage | Myocardial Infarction - prevention & control | Adrenergic beta-Antagonists - administration & dosage | Angiotensin Receptor Antagonists - administration & dosage | Research | Patient compliance | Coronary heart disease | Drugs | Myocardial infarction | Aspirin | Side effects | Enzyme inhibitors | Risk reduction | Age | Statins
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 11/2010, Volume 56, Issue 21, pp. 1701 - 1708
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9638, pp. 547 - 553
Summary Background Angiotensin receptor blockers (ARB) and angiotensin converting enzyme (ACE) inhibitors are known to reduce proteinuria. Their combination... 
Internal Medicine | COOPERATE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | RENIN-ANGIOTENSIN SYSTEM | DISEASE | PROTEINURIA | CONVERTING ENZYME-INHIBITORS | COMBINATION | NEPHROPATHY | II RECEPTOR BLOCKERS | PROGRESSION | Benzoates - adverse effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Benzoates - therapeutic use | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Ramipril - administration & dosage | Proteinuria - chemically induced | Cardiovascular Diseases - complications | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Benzimidazoles - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Ramipril - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | Ramipril - adverse effects | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Benzimidazoles - therapeutic use | Kidney - drug effects | Double-Blind Method | Diabetes Mellitus - drug therapy | Proteinuria - metabolism | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Creatinine - urine | Benzoates - administration & dosage | Creatinine - blood | Aged | Urine | Drugs | Studies | Kidneys | Disease | Clinical trials | Risk | ACE inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 09/2005, Volume 366, Issue 9489, pp. 895 - 906
The apparent shortfall in prevention of coronary heart disease (CHD) noted in early hypertension trials has been attributed to disadvantages of the diuretics... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | MANAGEMENT | MORBIDITY | DISEASE | GUIDELINES | DOUBLE-BLIND | CALCIUM-ANTAGONISTS | HYPERTENSION | INTERVENTION | Calcium Channel Blockers - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Bendroflumethiazide - administration & dosage | Hypertension - drug therapy | Male | Perindopril - administration & dosage | Sodium Chloride Symporter Inhibitors - administration & dosage | Diuretics | Adrenergic beta-Antagonists - adverse effects | Adult | Female | Blood Pressure - drug effects | Atenolol - administration & dosage | Drug Therapy, Combination | Amlodipine - administration & dosage | Adrenergic beta-Antagonists - administration & dosage | Risk Factors | Amlodipine - adverse effects | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Antihypertensive Agents - adverse effects | Coronary Disease - prevention & control | Calcium Channel Blockers - administration & dosage | Atenolol - adverse effects | Hypertension - complications | Aged | Hypertension | Antihypertensive drugs | Evaluation | Dosage and administration | Drug therapy | Prevention | Drug therapy, Combination | Health aspects | Coronary heart disease | Risk factors | Studies | Drugs | Cardiovascular disease | Medical treatment | Myocardial infarction | Heart attacks | Clinical trials | Family medical history | Blood | Randomization | Motivation | Blood pressure | Heart diseases | Antihypertensive agents | Cerebral infarction | Stroke | Fasting | Mortality | Diabetes mellitus | Health risks | Triglycerides | Metabolism | Risk analysis | Atenolol | Fatal | Patients | Coronary artery disease | Cholesterol | Heart rate | Infarction | Diabetes | Cardiovascular diseases | Health risk assessment | Potassium | Amlodipine/administration & dosage/adverse effects | Bendroflumethiazide/administration & dosage | Cardiovascular Diseases/prevention & control | Perindopril/administration & dosage | MEDICIN OCH HÄLSOVETENSKAP | Atenolol/administration & dosage/adverse effects | Combination | Antihypertensive Agents/administration & dosage/adverse effects | Angiotensin-Converting Enzyme Inhibitors/administration & dosage | MEDICAL AND HEALTH SCIENCES | Coronary Disease/prevention & control | Drug Therapy | Adrenergic beta-Antagonists/administration & dosage/adverse effects | Blood Pressure/drug effects | Hypertension/complications/drug therapy | Calcium Channel Blockers/administration & dosage/adverse effects | Sodium Chloride Symporter Inhibitors/administration & dosage
Journal Article
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ISSN 0735-1097, 06/2001, Volume 37, Issue 7, pp. 1808 - 1812
OBJECTIVES The objective of this study was to assess whether the angiotensin-converting enzyme (ACE) gene insertion/deletion (L/D) polymorphism influences the... 
MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | GENE | MORBIDITY | DISEASE | DILATED CARDIOMYOPATHY | DELETION POLYMORPHISM | PROGRESSION
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 12/2009, Volume 20, Issue 12, pp. 2641 - 2650
Aldosterone promotes glomerular and tubular sclerosis independent of angiotensin II in animal models of diabetic nephropathy. Most human studies testing the... 
PRONE HYPERTENSIVE-RATS | VASCULAR INJURY | CONTROLLED-TRIAL | CARDIOVASCULAR OUTCOMES | ALDOSTERONE ANTAGONISM | HEART-FAILURE | RENAL OUTCOMES | UROLOGY & NEPHROLOGY | BLOOD-PRESSURE CONTROL | CHRONIC KIDNEY-DISEASE | ANTIHYPERTENSIVE TREATMENT | Angiotensin II Type 1 Receptor Blockers - adverse effects | Spironolactone - administration & dosage | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Hypertension - drug therapy | Male | Diabetic Nephropathies - physiopathology | Lisinopril - adverse effects | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Adult | Female | Bicarbonates - blood | Blood Pressure - drug effects | Albuminuria - urine | Drug Therapy, Combination | Hypertension - urine | Spironolactone - adverse effects | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Lisinopril - administration & dosage | Diabetic Nephropathies - urine | Mineralocorticoid Receptor Antagonists - administration & dosage | Double-Blind Method | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Creatinine - urine | Hypertension - physiopathology | Albuminuria - drug therapy | Losartan - adverse effects | Potassium - blood | Renin-Angiotensin System - drug effects | Losartan - administration & dosage | Index Medicus | Clinical Research
Journal Article